GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Book Value per Share

Tissue Regenix Group (LSE:TRX) Book Value per Share : £0.34 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Book Value per Share?

Tissue Regenix Group's book value per share for the quarter that ended in Dec. 2023 was £0.34.

During the past 12 months, Tissue Regenix Group's average Book Value Per Share Growth Rate was -7.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -6.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -36.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -23.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Tissue Regenix Group was 29.80% per year. The lowest was -50.70% per year. And the median was -8.10% per year.

Tissue Regenix Group's current price is £0.685. Its book value per share for the quarter that ended in Dec. 2023 was £0.34. Hence, today's PB Ratio of Tissue Regenix Group is 2.03.

During the past 13 years, the highest P/B Ratio of Tissue Regenix Group was 11.79. The lowest was 0.14. And the median was 2.28.


Tissue Regenix Group Book Value per Share Historical Data

The historical data trend for Tissue Regenix Group's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Book Value per Share Chart

Tissue Regenix Group Annual Data
Trend Jan14 Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.15 0.41 0.37 0.37 0.34

Tissue Regenix Group Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.37 0.37 0.35 0.34

Competitive Comparison of Tissue Regenix Group's Book Value per Share

For the Biotechnology subindustry, Tissue Regenix Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tissue Regenix Group's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's PB Ratio falls into.



Tissue Regenix Group Book Value per Share Calculation

Tissue Regenix Group's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(23.82-0.00)/70.57
=0.34

Tissue Regenix Group's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(23.82-0.00)/70.57
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Tissue Regenix Group  (LSE:TRX) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Tissue Regenix Group Book Value per Share Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Tissue Regenix Group (LSE:TRX) Business Description

Traded in Other Exchanges
Address
Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.